Leukemia-lymphoma cell lines are important research tools in a variety of fields. To represent adequate model systems it is of utmost importance that cell lines faithfully model the primary tumor material and are not cross-contaminated with unrelated cell material (or contaminated with mycoplasma). As it has been previously reported that cross-contaminated cell lines represent a significant problem, it is of interest to know whether any improvement in the prevalence of such "false cell lines" had occurred since we called the alert in 1999. A retrospective review of our data archives covered 848 cell lines received from 1990 to 2014 from 290 laboratories in 23 countries spanning the spectrum of leukemia-lymphoma entities. Two variables were considered: authenticity and freedom from mycoplasma infection. Regarding provenance, we separately considered primary sources (original investigators having established the cell lines or reference repositories) and secondary sources. The percentages of mycoplasma-contaminated cell lines decreased significantly over the 25-year timespan. Among primary sourced material: mycoplasma-contamination fell from 23% to 0%; among secondary sourced: from 48% to 21%. The corresponding figures for cross-contamination declined from 15% to 6%, while among material obtained from secondary sources prevalence remained remarkably high, throughout the time periods at 14-18%. Taken together, our data indicate that using non-authenticated cell lines from secondary sources carries a risk of about 1:6 for obtaining a false cell line. The use of authentic leukemia-lymphoma cell lines holds important translational value for their model character and the reproducibility of the laboratory data in the clinical arena.
Introduction
Tumor cell lines are important research tools which over the last decades have contributed significantly to progress knowledge in a variety of fields, recently broadly depicting the genomic diversity of cancer and providing valuable insight into their pathobiology. 1, 2 However, there are several significant problems that have plagued this area of research: notably, contamination with mycoplasma or with other cell lines ("false cell lines"), refusal of scientists to provide cell lines upon request, black market (unchecked trafficking of cell lines between labs), excessive bureaucracy and legal issues.
In a series of articles we have documented the widespread cross-contamination of tumor cell lines in general and in leukemia-lymphoma-derived cell lines in particular. 3, 4 Detection of mycoplasma-contamination and authentication of cell lines have markedly changed over the last decades with the introduction of new diagnostic tools, but it is not clear whether this had led to sustained improvements in the prevalence of mycoplasma-positive and false cell lines.
The objective of our study was to monitor progress in combating these twin problems of cell culture over several decades. To that end we studied 848 leukemia-lymphoma cell lines received between 1990 and 2014. We chose 1990 as the start date as that was the earliest year for which we had previously banked specimens. Improvements were primarily Key words: authentification, cell lines, leukemia, lymphoma, mycoplasma Additional Supporting Information may be found in the online version of this article. Disclosure: All authors are employees of the Leibniz-Institute DSMZ which is a non-profit research institute owned by the German government. For these studies no research funding had been received. Brief Description Tumor cell lines are essential research tools, but a significant percentage is contaminated with other cell lines and/or mycoplasma. Our study, spanning 25 years of data, documents that the incidence of mycoplasma-contamination decreased significantly over that time-span. seen in the area of mycoplasma-contamination. Although in recent years cell lines obtained directly from the primary source were less likely to be cross-contaminated than in previous decades, secondarily sourced cell lines which travel unchecked from lab to lab across the world remained a significant problem. The spirit of the recommendations issued in this paper is that cell lines should not be obtained cavalier unauthenticated and without quality control from the neighboring lab or ambiguous sources but from reputable certified facilities.
Materials and Methods

Cell lines
Cell lines, all established from patients with a variety of hematopoietic neoplasms (leukemia, lymphoma and myeloma) were received directly from the laboratory where the cell line had been established (original investigators, primary source) or indirectly from secondary laboratories (secondary source). The minority of cell lines obtained from certified cell line banks (n 5 34) were assigned to the category "primary source." Details on the cell culture and the characteristics of the cell lines have been summarized elsewhere. 5 
Mycoplasma detection
Cell lines were initially examined with regard to mycoplasmacontamination. Four different methods were variously used from 1990 to 2014 (Fig. 1) . For the first 10 years the following three assays were employed: (1) DAPI (4 0 ,6-diamidino-2-phenylindole) is a fluorescent dye which is widely used for the microscopic detection of DNA under UV light; (2) Gen Probe (from Gen Probe, San Diego, CA, USA) was a nucleic acid hybridization assay which targeted mycoplasma rRNA for detection by a radioactivity assay (now as non-isotopic detection kit distributed by Millipore); (3) the microbiological assay examining colony growth of mycoplasma on agar plates which is still regarded as the gold standard for mycoplasma detection. Later a mycoplasma genus-specific polymerase chain reaction (PCR) was developed in this laboratory which we found to be the most sensitive and reliable method. Further details are summarized elsewhere. 6, 7 
DNA fingerprinting
Over the 25-year timespan the DNAs prepared from the received cell lines were examined using the multilocus VNTR (variable number tandem repeat) and STR (short tandem repeat), methods ( Fig. 1) . All samples received after 2000 were routinely tested by STR profiling; DNA samples from previously banked specimens received prior to 2000 were retested by STR profiling. Technical details have been described elsewhere. [8] [9] [10] The database for authentication of cell lines has been described previously.
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Cytogenetic analysis
Since 1990 standard karyology and G-banding are used to characterize cell lines, respectively yielding modal chromosome counts and karyotypes. In addition whole chromosome painting (from 1992 until 2011) and FISH (fluorescence in situ hybridization since 1993) were applied as routine methods. SKY (spectral karyotyping since 2011) and aCGH (array comparative genomic hybridization since 2011) were employed as additional specialist methods to aid karyotype interpretation, notably by revealing cryptic structural and numerical alterations. Specific technical details have been described elsewhere.
12,13
Results
Our analysis was based on 848 cell cultures obtained from 1990 to 2014 from 290 laboratories in 23 countries that span the spectrum of malignant hematopoietic cell lines (derived from patients with leukemia, lymphoma or myeloma). In the following the "calendar years" refer to date of receipt of cell lines (to provide an accurate reflection of the situation during that particular time window); stored specimens received prior to the availability of certain diagnostic assays were retested using the most modern mycoplasma and STR analyses.
The situation in 1990-1993
During the period 1990-1993 273 leukemia-lymphoma cell lines were received and tested for mycoplasma-contamination and authenticity (Fig. 2a) . Of these, 161 (59%) were mycoplasmanegative and authentic; 71 (26%) were mycoplasma-positive and authentic; 22 (8%) were mycoplasma-positive and false; 19 (7%) were mycoplasma-negative and false.
Trends in mycoplasma-contamination from 1990 to 2014
The percentages of mycoplasma-contaminated cell lines were then calculated by calendar periods, according to cell line provenances (as primary versus secondary sources) (Fig. 3a) . Levels of mycoplasma-infestation decreased significantly over the 25 years (detailed data are listed in Supplementary Table S1 ). However, while all 44 primary source cell lines received between 2010 and 2014 were negative, 21% (n 5 19) secondary source cell lines were mycoplasma-positive.
Trends in cell lines cross-contamination from 1990 to 2014
Timeline data are again divided according to provenance (Fig. 3b) . While the number of cross-contaminated cell lines among original source cell lines decreased, the percentage of false cell lines from secondary sources remained stubbornly high and clearly increased again over the last 10-15 years (detailed data are shown in Supplementary Table S2 ).
The situation in 2010-2014 Figure 2b shows the status of 57 cell lines received between 2010 and 2014 and for which data on authenticity and mycoplasma are both available. Of these, 47 (82%) were both authentic and mycoplasma-negative; between 2% and 11% of the cell lines displayed one of the other three possible combinations: 1 false/mycoplasma1; 3 authentic/mycoplasma1; 6 false/mycoplasma-negative.
Most prolific contaminants
The most frequent cross-contaminating cell lines could be described as (1) classical examples (established in the 1960 sec and 1970 sec) and used widely all over the world; and (2) having relatively short doubling times (thus readily overgrowing slower "novice" cell lines). The most prolific contaminants and their STR profiles are listed in Supplementary Table S3 . 
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Discussion
Our study of 848 leukemia-lymphoma cell lines received between 1990 and 2014 from 290 laboratories in 23 countries is the first analysis to address whether alerts which first appeared toward the end of the 1990 sec have been accompanied by possible improvements in the prevalence of mycoplasma-positive or cross-contaminated cell lines thereafter. We show that after the advent of improved diagnostic and therapeutic possibilities in the field of mycoplasma-detection and -elimination the number of mycoplasma-positive cell lines decreased significantly. Also with regard to the prevalence of false cell lines some improvements occurred. Here, an amelioration was seen for primary source cell lines to the exclusion of secondary source cell lines where free unchecked exchange between labs is rather the rule. The apparent increase in the rate in false cell lines in 2010-2014 versus the two previous time periods is reason for concern and the further development need to be observed closely.
We conclude that the following technical advances, measures and actions have in all likelihood driven the sustained betterment and correction of the mycoplasma-problem (Table  1) : (i) the advent of PCR which allows for a rapid, cheap, sensitive and robust detection method; 6 (ii) a range of effective antimycoplasma antibodies efficacious for the permanent eradication of these bacteria; 14 (iii) the improved cell culture practices though this is both doubtful and difficult to ascertain and (iv) increased awareness due to extensive publishing on the subject raising awareness of the problem and providing relatively simple solutions. 15 Together taken, the diagnosis of mycoplasmacontamination of cell lines has become relatively straightforward, anti-mycoplasma treatment is efficient, and hence the prognosis for a mycoplasma-free cell culture is excellent.
We also identified several reasons for the improvement of the false cell lines problem, contributing in various degrees (Table 2 ): (i) technical advances, such as the introduction of STR profiling and the availability of web-based DNA fingerprint databases are instrumental innovations; 11 (ii) using the new tools it was possible to bring together the major cell line banks in an unprecedented initiative, agreeing on common standards, sharing an interactive reference database and cleaning up the inventories of these cell line banks; 16 (iii) capitalizing on this forward momentum, the International Cell Line Authentication Committee (ICLAC) was established in 2012. 17 ICLAC is an ad hoc board which unites cell authentication specialists from leading cell line banks, industry and academia to make cell line misidentification more visible, to promote awareness and authentication testing, and curate a continually updated blacklist of false cell lines 18 and (iv) last but not least extensive publishing on that topic appears to have raised awareness. 3, 4, 10, 19, 20 Dr Walter NelsonRees was the first who exposed and sounded the alarm on the wide-spread problem of cross-contamination of cell lines. 21 In the 1970 sec he used cytogenetic techniques showing that many cell lines, previously thought to be unique, were actually HeLa cell lines due to cross-contamination and overgrowth of the other cell lines.
We leveraged DNA fingerprinting using the STR technology to show that a practical, robust and cost-effective system is available with which to tackle the cross-contamination problem. 22 Further ways to minimize this problem include A meticulous approach to cell line authentication is definitely warranted and an essential component of good cell culture practice.
Acknowledging that STR profiling also has limitations caused, for example, when allelic drift combined with losses in heterozygosity serve to generate apparently distinct profiles, improved methods of genomic identification are being sought. One candidate involves the use of single nucleotide polymorphisms which yield extensive data sets sufficiently robust to enable problems associated with drift to be sidestepped, while requiring correspondingly powerful high throughput data analysis tools.
In recent years, cell lines have become vital research tools. For example large-scale screenings of clinically relevant agents using molecularly annotated cell lines have become an integral part of pharmacogenomics. 2 Hence, meaningful use of cell lines as a crucial preclinical resource in such large cancer cell line collections like the Cancer Cell Line Encyclopedia (CCLE), 1 the Genomics of Drug Sensitivity in Cancer (GDSC), 24 the Wellcome Trust Sanger Centre and the NCI-60 panel 25 demands rigorous authentication and freedom from cryptic microorganismcontamination. We bring attention to these imperatives not only to define best cell culture practice, but also to help move the management of cell line panels from the realm of neglected dusty lab corners and cell culture by inexperienced and inattentive cell culturists to high-level professional standards.
Taken together, we observed an improvement with regard to mycoplasma-contamination of cell lines. Alas, about one in six cell line cultures freely trafficked within the scientific community remain cross-contaminated, highlighting a practice tolerated by even "top" scientific journals -clearly a lamentable situation. This amounts to playing scientific Russian roulette with an integral part of the research material. Our study covering more than two decades and on cell lines from nearly three hundred laboratories in two dozen countries documents the chronic prevalence of the two major problems plaguing cell culture.
The fact that one out of six cell line on the "gray market" are cross-contaminated provides strong rationale to mandate use of cell lines which have been properly authenticated, e.g. at non-profit institutionalized cell line repositories. At the same time deposition of new cell lines in such reference cell banks is required to facilitate access to clean and authentic cell lines since "private" cell lines which bypass the authentication system thereby denied both authentication and independent characterization are at heightened risk of cross-contamination and misclassification. Ultimately, to move forward meaningfully in the direction of continued improvement the most important factor is to spread awareness regarding the scientific danger of false cell lines, not merely in the generation of misleading data but the risk that it poses to the detriment of the resource itself, a peril which needs yet to be fully appreciated. 
